Deuterium inventory in Tore Supra: Coupled carbon–deuterium balance von Pégourié, B., Panayotis, S., Languille, P., Martin, C., Dittmar, T., Gauthier, E., Hatchressian, J.-C., Pascal, J.-Y., Roubin, P., Ruffe, R., Tsitrone, E., Vartanian, S., Wang, H., Beauté, A., Bouvet, J., Brosset, C., Bucalossi, J., Cabié, M., Caprin, E., Courtois, X., Dachicourt, R., Delchambre, E., Dominici, C., Douai, D., Ekedahl, A., Gunn, J.P., Hakola, A., Jacob, W., Khodja, H., Likonen, J., Linez, F., Litnovsky, A., Marandet, Y., Markelj, S., Martinez, A., Mayer, M., Meyer, O., Monier-Garbet, P., Moreau, P., Negrier, V., Oddon, P., Pardanaud, C., Pasquet, B., Pelicon, P., Petersson, P., Philipps, V., Possnert, G., Reiter, D., Roth, J., Roure, I., Rubel, M., Saint-Laurent, F., Samaille, F., Vavpetič, P.

Volltext

Deuterium inventory in Tore Supra: Contribution of carbon deposits outgassing von Panayotis, S., Pégourié, B., Caprin, E., Douai, D., Hatchressian, J.-C., Negrier, V., Pascal, J.-Y., Vartanian, S., Bucalossi, J., Monier-Garbet, P.

Volltext

Validation of CW High Power Sources and RF Components for the Tore Supra LHCD System von Delpech, L, Achard, J, Berger-By, G, Bouquey, F, El Khaldi, M, Guilhem, D, Goletto, C, Hillairet, J, Magne, R, Marfisi, L, Mollard, P, Negrier, V, Poli, S, Prou, M, Samaille, F, Volpe, D, Kazarian, F, Beunas, A, Boghossian, E

Volltext

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors von Mahlangu, Johnny, Oldenburg, Johannes, Paz-Priel, Ido, Negrier, Claude, Niggli, Markus, Mancuso, M. Elisa, Schmitt, Christophe, Jiménez-Yuste, Victor, Kempton, Christine, Dhalluin, Christophe, Callaghan, Michael U, Bujan, Willem, Shima, Midori, Adamkewicz, Joanne I, Asikanius, Elina, Levy, Gallia G, Kruse-Jarres, Rebecca

Volltext

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia von Sehgal, Alfica, Barros, Scott, Ivanciu, Lacramioara, Cooley, Brian, Qin, June, Racie, Tim, Hettinger, Julia, Carioto, Mary, Jiang, Yongfeng, Brodsky, Josh, Prabhala, Harsha, Zhang, Xuemei, Attarwala, Husain, Hutabarat, Renta, Foster, Don, Milstein, Stuart, Charisse, Klaus, Kuchimanchi, Satya, Maier, Martin A, Nechev, Lubo, Kandasamy, Pachamuthu, Kel'in, Alexander V, Nair, Jayaprakash K, Rajeev, Kallanthottathil G, Manoharan, Muthiah, Meyers, Rachel, Sorensen, Benny, Simon, Amy R, Dargaud, Yesim, Negrier, Claude, Camire, Rodney M, Akinc, Akin

Volltext

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma von Montemagno, Christopher, Durivault, Jérôme, Gastaldi, Cécile, Dufies, Maeva, Vial, Valérie, He, Xingkang, Ambrosetti, Damien, Kamenskaya, Anna, Negrier, Sylvie, Bernhard, Jean‐Christophe, Borchiellini, Delphine, Cao, Yihai, Pagès, Gilles

Volltext

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement von Iorio, A., Iserman, E., Blanchette, V., Dolan, G., Escuriola Ettingshausen, C., Hermans, C., Negrier, C., Oldenburg, J., Reininger, A., Rodriguez‐Merchan, C., Spannagl, M., Valentino, L. A., Young, G., Steinitz‐Trost, K. N., Gringeri, A.

Volltext

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J

Volltext

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A von Mahlangu, Johnny, Powell, Jerry S., Ragni, Margaret V., Chowdary, Pratima, Josephson, Neil C., Pabinger, Ingrid, Hanabusa, Hideji, Gupta, Naresh, Kulkarni, Roshni, Fogarty, Patrick, Perry, David, Shapiro, Amy, Pasi, K. John, Apte, Shashikant, Nestorov, Ivan, Jiang, Haiyan, Li, Shuanglian, Neelakantan, Srividya, Cristiano, Lynda M., Goyal, Jaya, Sommer, Jurg M., Dumont, Jennifer A., Dodd, Nigel, Nugent, Karen, Vigliani, Gloria, Luk, Alvin, Brennan, Aoife, Pierce, Glenn F.

Volltext

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib von Beuselinck, B, Karadimou, A, Lambrechts, D, Claes, B, Wolter, P, Couchy, G, Berkers, J, Paridaens, R, Schöffski, P, Méjean, A, Verkarre, V, Lerut, E, de la Taille, A, Tourani, J-M, Bigot, P, Linassier, C, Négrier, S, Berger, J, Patard, J-J, Zucman-Rossi, J, Oudard, S

Volltext

Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion von Chevalier, Y., Dargaud, Y., Lienhart, A., Chamouard, V., Negrier, C.

Volltext

Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study von Dargaud, Y, Luddington, R, Gray, E, Lecompte, T, Siegemund, T, Baglin, T, Hogwood, J, Regnault, V, Siegemund, A, Negrier, C

Volltext

Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma: Final Results and Analysis of Prognostic Factors von MOTZER, Robert J, ESCUDIER, Bernard, KAY, Andrea, RAVAUD, Alain, OUDARD, Stephane, HUTSON, Thomas E, PORTA, Camillo, BRACARDA, Sergio, GRÜNWALD, Viktor, THOMPSON, John A, FIGLIN, Robert A, HOLLAENDER, Norbert

Volltext

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial von Santagostino, Elena, Martinowitz, Uri, Lissitchkov, Toshko, Pan-Petesch, Brigitte, Hanabusa, Hideji, Oldenburg, Johannes, Boggio, Lisa, Negrier, Claude, Pabinger, Ingrid, von Depka Prondzinski, Mario, Altisent, Carmen, Castaman, Giancarlo, Yamamoto, Koji, Álvarez-Roman, Maria-Teresa, Voigt, Christine, Blackman, Nicole, Jacobs, Iris

Volltext

ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma von Ascierto, P.A., Arenberger, P., Atkinson, V.G., Hansson, J., Kapiteijn, E., Loquai, C., Negrier, S., Shaw, H.M., Tarhini, A., Walker, J., Geib, J., Rahimian, S., Swann, S., Diab, A.

Volltext

Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability von Jourdy, Y., Chatron, N., Carage, M.‐L., Fretigny, M., Meunier, S., Zawadzki, C., Gay, V., Negrier, C., Sanlaville, D., Vinciguerra, C.

Volltext

Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling von Jourdy, Y., Chatron, N., Fretigny, M., Carage, M. L., Chambost, H., Claeyssens‐Donadel, S., Roussel‐Robert, V., Negrier, C., Sanlaville, D., Vinciguerra, C.

Volltext

Leber’s optic neuropathy associated with disseminated white matter disease: A case report and review von Perez, F, Anne, O, Debruxelles, S, Menegon, P, Lambrecq, V, Lacombe, D, Martin-Negrier, M.L, Brochet, B, Goizet, C

Volltext

Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial von Choueiri, T K, Penkov, K, Uemura, H, Campbell, M T, Pal, S, Kollmannsberger, C, Lee, J L, Venugopal, B, van den Eertwegh, A J M, Negrier, S, Gurney, H, Albiges, L, Berger, R, Haanen, J B A G, Oyervides Juárez, V, Rini, B I, Larkin, J, Nolè, F, Schmidinger, M, Atkins, M B, Tomita, Y, Ellers-Lenz, B, Hoffman, J, Sandner, R, Wang, J, di Pietro, A, Motzer, R J

Volltext

1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis... von Gruenwald, V., McKay, R.R., Buchler, T., Eto, M., Park, S.H., Takagi, T., Zanetta, S., Keizman, D., Rodriguez, C. Suarez, Negrier, S., Lee, J-L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C.K., Choueiri, T.K., Motzer, R.J., Burgents, J., Okpara, C.E., Powles, T.B.

Volltext